Bacillus Calmette-Guérin (BCG) Vaccination in Infancy and Risk of Childhood Diabetes

Paediatric and Perinatal Epidemiology

Volumn 30, Issue 2, 2016, Pages 141-148

  Rousseau, Marie Claude ^a   El Zein, Mariam ^a   Conus, Florence ^a   Legault, Laurent ^b   Parent, Marie Elise ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

administrative health databases; Bacillus Calmette Gu rin; BCG; birth cohort; diabetes

Indexed keywords

BCG VACCINE;

ARTICLE; BCG VACCINATION; CANADA; CHILDHOOD DISEASE; COHORT ANALYSIS; DATA BASE; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOSTIMULATION; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT CODING; POPULATION RESEARCH; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH SERVICE; REGISTER; RISK ASSESSMENT; TUBERCULOSIS; CHILD; DIABETES MELLITUS, TYPE 1; MATERNAL AGE; PATERNAL AGE; QUEBEC; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VACCINATION;

BCG VACCINE; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; HUMANS; INFANT; MATERNAL AGE; PATERNAL AGE; QUEBEC; RISK FACTORS; VACCINATION;

EID: 84960380822     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/ppe.12263     Document Type: Article

References (35)

1. Patterson C, Guariguata L, Dahlquist G, Soltesz G, Ogle G, Silink M,. Diabetes in the young-a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Research and Clinical Practice 2014; 103: 161-175.
2. Stankov K, Benc D, Draskovic D,. Genetic and epigenetic factors in etiology of diabetes mellitus type 1. Pediatrics 2013; 132: 1112-1122.
3. Stene LC, Gale EA,. The prenatal environment and type 1 diabetes. Diabetologia 2013; 56: 1888-1897.
4. Cardwell CR, Stene LC, Ludvigsson J, Rosenbauer J, Cinek O, Svensson J, et al. Breast-feeding and childhood-onset type 1 diabetes: A pooled analysis of individual participant data from 43 observational studies. Diabetes Care 2012; 35: 2215-2225.
5. EURODIAB Substudy 2 Study Group. Infections and vaccinations as risk factors for childhood type I (insulin-dependent) diabetes mellitus: A multicentre case-control investigation. Diabetologia 2000; 43: 47-53.
6. Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, De Groote D, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. The Journal of Immunology 1999; 163: 2249-2255.
7. Jaron B, Maranghi E, Leclerc C, Majlessi L,. Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis. PLoS ONE 2008; 3: e2833.
8. Kleinnijenhuis J, Quintin J, Preijers F, Benn CS, Joosten LA, Jacobs C, et al. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. The Journal of Innate Immunity 2014; 6: 152-158.
9. Solt LA, Banerjee S, Campbell S, Kamenecka TM, Burris TP,. ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes. Endocrinology 2015; 156: 869-881.
10. Rousseau MC, Parent ME, St-Pierre Y,. Potential health effects from non-specific stimulation of the immune function in early age: The example of BCG vaccination. Pediatric Allergy and Immunology 2008; 19: 438-448.
11. Sankoh O, Welaga P, Debpuur C, Zandoh C, Gyaase S, Poma MA, et al. The non-specific effects of vaccines and other childhood interventions: The contribution of INDEPTH Health and Demographic Surveillance Systems. The International Journal of Epidemiology 2014; 43: 645-653.
12. Holt PG, Jones CA,. The development of the immune system during pregnancy and early life. Allergy 2000; 55: 688-697.
13. Harada M, Kishimoto Y, Makino S,. Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Research and Clinical Practice 1990; 8: 85-89.
14. da Rosa LC, Chiuso-Minicucci F, Zorzella-Pezavento SF, Franca TG, Ishikawa LL, Colavite PM, et al. Bacille Calmette-Guerin/DNAhsp65 prime-boost is protective against diabetes in non-obese diabetic mice but not in the streptozotocin model of type 1 diabetes. Clinical & Experimental Immunology 2013; 173: 430-437.
15. Blom L, Nystrom L, Dahlquist G,. The Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia 1991; 34: 176-181.
16. Dahlquist G, Gothefors L,. The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia 1995; 38: 873-874.
17. Hummel M, Fuchtenbusch M, Schenker M, Ziegler AG,. No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study. Diabetes Care 2000; 23: 969-974.
18. Huppmann M, Baumgarten A, Ziegler AG, Bonifacio E,. Neonatal Bacille Calmette-Guerin vaccination and type 1 diabetes. Diabetes Care 2005; 28: 1204-1206.
19. Parent ME, Siemiatycki J, Menzies R, Fritschi L, Colle E,. Bacille Calmette-Guerin vaccination and incidence of IDDM in Montreal, Canada. Diabetes Care 1997; 20: 767-772.
20. Wadsworth EJ, Shield JP, Hunt LP, Baum JD,. A case-control study of environmental factors associated with diabetes in the under 5s. Diabetic Medicine 1997; 14: 390-396.
21. Wahlberg J, Fredriksson J, Vaarala O, Ludvigsson J,. Vaccinations may induce diabetes-related autoantibodies in one-year-old children. Annals of the New York Academy of Sciences 2003; 1005: 404-408.
22. Li J, Menzies D, Landry JS, Benedetti A, Rousseau MC,. Determinants of Bacillus Calmette-Guerin (BCG) vaccination among Quebec children. Preventive Medicine 2014; 66C: 87-94.
23. Public Health Agency of Canada. Report from the National Diabetes Surveillance System: Diabetes in Canada 2008.
24. Guttmann A, Nakhla M, Henderson M, To T, Daneman D, Cauch-Dudek K, et al. Validation of a health administrative data algorithm for assessing the epidemiology of diabetes in Canadian children. Pediatric Diabetes 2010; 11: 122-128.
25. Kramer MS, Platt RW, Wen SW, Joseph KS, Allen A, Abrahamowicz M, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001; 108: E35.
26. Canada Post. Addressing Guidelines [Report]. 2015. http://www.canadapost.ca/tools/pg/manual/PGaddress-e.pdf [last accessed November 2015].
27. Cardwell CR, Shields MD, Carson DJ, Patterson CC,. A meta-analysis of the association between childhood type 1 diabetes and atopic disease. Diabetes Care 2003; 26: 2568-2574.
28. Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T,. Identifying patients with physician-diagnosed asthma in health administrative databases. Canadian Respiratory Journal 2009; 16: 183-188.
29. Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M,. The BCG World Atlas: A database of global BCG vaccination policies and practices. PLoS Medicine 2011; 8: e1001012.
30. Rousseau MC, Conus F, Kâ K, El-Zein M,. Description of Bacillus Calmette-Guérin (BCG) vaccination rates in the province of Quebec, Canada, 1926-1974. American Journal of Epidemiology (Supplement) 2012; 175 (11): S33 [131].
31. Vanderloo SE, Johnson JA, Reimer K, McCrea P, Nuernberger K, Krueger H, et al. Validation of classification algorithms for childhood diabetes identified from administrative data. Pediatric Diabetes 2012; 13: 229-234.
32. Dart AB, Martens PJ, Sellers EA, Brownell MD, Rigatto C, Dean HJ,. Validation of a pediatric diabetes case definition using administrative health data in Manitoba, Canada. Diabetes Care 2011; 34: 898-903.
33. Gregory E, Crouse DL, Krishnamoorthy P, Legault L,. Comparisons of type 1 and 2 diabetes socioeconomic characteristics in a Montreal pediatric clinic. Canadian Journal of Diabetes 2010; 34: 340-345.
34. Rousseau MC, Conus F, Li J, Parent ME, El-Zein M,. The Quebec BCG Vaccination Registry (1956-1992): Assessing data quality and linkage with administrative health databases. BMC Medical Informatics and Decision Making 2014; 14: 2.
35. Régie des rentes du Québec. Eligibility requirements for the supplement for handicapped children. 2015. http://www.rrq.gouv.qc.ca/en/enfants/enfant-handicape/Pages/criteres-admissibilite.aspx [last accessed November 2015].